Takeda/Zinfadel terminate late-stage Alzheimer’s study
Alzheimer’s disease research has taken another hit with the termination of a Phase III study assessing the effect of diabetes drug pioglitazone on mild cognitive impairment (MCI) in patients with the condition.
Read More
